ABOUT THE EVENT
Date: Wednesday, July 22, 2026 11am EDT
Event Location: Virtual
Bispecific antibodies represent a rapidly expanding class of biotherapeutics, presenting distinct innovation trends across multiple fields including molecular engineering, process development, large scale manufacturing, and commercialization. However, the production process faces many bottlenecks: the tendency of aggregation of the molecules, the difficulty in removing product-related impurities, the stringent requirements for process compatibility.
This presentation will dive into the cutting-edge expertise and enabling technologies designed to streamline and integrate the full downstream purification workflow, while simultaneously boosting overall process efficiency, batch-to-batch consistency, and end-product quality profiles.
Key Learning Objectives
- The value and prospects of bispecific antibodies
- Challenges in downstream process development and large scale production
- Case study and strategies for asymmetric bispecific antibody
- Strategies of viral clearance studies
